Table 1.

Unilateral Wilms tumor patient demographics and clinical characteristics. Numbers are represented as number (%) or median [interquartile range]. VA – vincristine and actinomycin-D, VAD – vincristine, actinomycin-D, doxorubicin

	Total N = 48
Age (years) [IQR]	3.5 [4.00]
Biological sex
Female	28 (58.3)
Male	20 (41.7)
Race
White	28 (58.3)
Black	11 (22.9)
Asian	1 (2.0)
Hispanic	1 (2.0)
Other	4 (8.3)
Disease Stage
I	5 (10.4)
II	12 (25.0)
III	12 (25.0)
IV	19 (39.6)
Adjuvant Chemotherapy Drugs
VA	15 (31.3)
VAD	27 (56.3)
Other	6 (12.5)
30-day postoperative complications	3 (6.3)
Intussusception	2 (4.2)
Small Bowel Obstruction	1 (2.1)
Wound dehiscence or infection	0 (0)
Adjuvant Chemotherapy Initiation
Time to Initiation (Days) [IQR]	11.0 [7, 14]
≤7 days	12 (25)
8-14 days	29 (60.4)
≥15 days	7 (14.6)